BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/9/2022 12:48:14 PM | Browse: 707 | Download: 2052
 |
Received |
|
2022-01-21 05:28 |
 |
Peer-Review Started |
|
2022-01-21 05:29 |
 |
First Decision by Editorial Office Director |
|
2022-02-24 07:20 |
 |
Return for Revision |
|
2022-02-25 10:15 |
 |
Revised |
|
2022-03-12 08:33 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2022-07-25 07:59 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2022-07-31 19:33 |
 |
Articles in Press |
|
2022-07-31 19:33 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2022-08-26 01:36 |
 |
Publish the Manuscript Online |
|
2022-09-09 12:48 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
To scope or not - the challenges of managing patients with positive fecal occult blood test after recent colonoscopy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Nivedita Rattan, Laura Willmann, Diana Aston, Shani George, Milan Bassan, David Abi-Hanna, Sulakchanan Anandabaskaran, George Ermerak, Watson Ng and Jenn Hian Koo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jenn Hian Koo, FRACP, MBBS, PhD, Doctor, Doctor, Gastroenterology and Liver Services, Liverpool Hospital, Elizabeth Street, Liverpool 2170, New South Wales, Australia. jenn.koo@health.nsw.gov.au |
| Key Words |
Colorectal cancer; Adenoma; Screening; Fecal occult blood test; Colonoscopy |
| Core Tip |
Currently, there is minimal consensus to inform clinicians of the appropriate approach to manage patients presenting with positive immunochemical fecal occult blood test (iFOBT) following a recent colonoscopy. This may lead to additional unnecessary, invasive procedure which confers procedure-related risks, as well as avoidable patient anxiety and a higher cost-burden on the healthcare system. Our study revealed that a previous colonoscopy, irrespective of its result, was associated with low prevalence of advanced neoplasia, and if performed within 4 years of a positive iFOBT result, was protective against colorectal cancer. |
| Publish Date |
2022-09-09 12:48 |
| Citation |
Rattan N, Willmann L, Aston D, George S, Bassan M, Abi-Hanna D, Anandabaskaran S, Ermerak G, Ng W, Koo JH. To scope or not - the challenges of managing patients with positive fecal occult blood test after recent colonoscopy. World J Gastrointest Oncol 2022; 14(9): 1798-1807 |
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i9/1798.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i9.1798 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.